期刊
EXPERT REVIEW OF CLINICAL IMMUNOLOGY
卷 6, 期 4, 页码 537-541出版社
EXPERT REVIEWS
DOI: 10.1586/ECI.10.44
关键词
Crohn's disease; IBD; IL-21; Th1 cells; Th17 cells; ulcerative colitis
类别
资金
- Fondazione Umberto di Mario, Rome
- Broad Medical Research Program Foundation [IBD-0154R]
- Giuliani SpA, Milan, Italy
IL-21 was first described as a critical regulator of T- and B-cell functions. More recently, it has become apparent that IL-21 controls the activity of both immune and nonimmune cells and, depending on the timing and context analyzed, it can promote either inflammatory or counter-regulatory effects. IL-21 participates in the immune responses against tumor cells and chronic viral infections, but excessive production of IL-21 has been associated with the development of immune-inflammatory diseases in various organs. In this article, we focus on data supporting the pathogenic role of IL-21 in human inflammatory bowel diseases and discuss preclinical studies that suggest that neutralization of IL-21 in vivo could be a new strategy to counteract the inflammatory bowel disease-related, tissue damaging immune response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据